FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14789411000001105: Azithromycin 250mg capsules (PLIVA Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
51757601000001113 Azithromycin 250mg capsules (PLIVA Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
54800001000001117 Azithromycin 250mg capsules (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Is a Product containing precisely azithromycin (as azithromycin dihydrate) 250 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Has active ingredient Azithromycin dihydrate false Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Azithromycin true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Has specific active ingredient Azithromycin dihydrate true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) Has basis of strength substance Azithromycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Azithromycin 250mg capsules (PLIVA Pharma Ltd) 6 capsule Is pack of False Azithromycin 250mg capsules (PLIVA Pharma Ltd) Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) 4 capsule Is pack of False Azithromycin 250mg capsules (PLIVA Pharma Ltd) Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) 6 capsule Has AMP True Azithromycin 250mg capsules (PLIVA Pharma Ltd) Inferred relationship Existential restriction modifier
Azithromycin 250mg capsules (PLIVA Pharma Ltd) 4 capsule Has AMP True Azithromycin 250mg capsules (PLIVA Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start